Skip to main content

Spasticity Due to Cerebral Palsy

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Syneos Health
Syneos HealthNC - Morrisville
1 program
1
Zanaflex CapsulesPhase 11 trial
Active Trials
NCT01405950Terminated10Est. Mar 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Syneos HealthZanaflex Capsules

Clinical Trials (1)

Total enrollment: 10 patients across 1 trials

NCT01405950Syneos HealthZanaflex Capsules

Phase 1b Study of Tizanidine in Pediatric Patients With Cerebral Palsy

Start: May 2011Est. completion: Mar 201210 patients
Phase 1Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.